Mapping of disease-associated variants in admixed populations by Shriner, Daniel et al.
A  major  goal  of  human  genetics  is  to  identify  genetic 
variation causally related to either Mendelian or complex 
diseases. More broadly, a fundamental goal of genetics is 
to describe the genetic architecture underlying any trait 
of interest. Most candidate gene studies, linkage studies, 
or genome-wide association studies to date have focused 
on  European  populations,  for  which  large  samples  of 
ancestrally  homogeneous  individuals  from  relatively 
homogeneous environments have been established. For 
example, approximately 90% of genome-wide association 
studies have been performed using samples of individuals 
with European ancestry [1]. However, expanding human 
genetic studies to include diverse worldwide populations 
is needed to: (i) identify novel loci absent or not readily 
identifiable  in  European  populations  due  to  low  allele 
frequencies  and  the  resulting  low  statistical  power; 
(ii) establish the extent to which findings from studies of 
European  populations  generalize  or  transfer  to  non-
European populations; and (iii) study diseases or traits, 
such  as  podoconiosis  and  human  African  trypano-
somiasis  (sleeping  sickness),  present  in  non-European 
populations only [2-4].
In this article, we highlight the special value of admixed 
populations  in  disease  mapping  studies.  Admixed 
populations are not ancestrally homogeneous but rather 
are  populations  with  ancestry  from  more  than  one 
parental  population.  Admixed  populations  that  have 
successfully contributed to the mapping of susceptibility 
loci include African Americans, who have African and 
European  ancestry,  and  Latino  Americans,  who  have 
African, European, and Native American ancestry. These 
admixed populations afford opportunities for the study of 
health inequalities or group differences, which can occur 
when  there  are  differences  in  traits  such  as  disease 
susceptibility (for example, a 2.8-fold increase in risk for 
hypertensive  heart  disease  in  African  Americans 
compared  with  European  Americans  [5])  or  drug 
response  (for  example,  differential  response  between 
populations  with  African  and  European  ancestry  to 
peginterferon α-2a or peginterferon α-2b combined with 
ribavirin, which are used to treat chronic infection with 
the hepatitis C virus [6]). Such differences result from a 
combination  of  environmental  and  genetic  differences, 
the latter of which are our focus.
Admixture mapping and association mapping studies 
in admixed populations are poised to enter a new era as a 
result of the availability of economical high-throughput 
genotyping and sequencing. To date, ancestry has been 
estimated  using  panels  containing  <10,000  highly 
ascertained  markers  known  as  ancestry-informative 
markers  (AIMs)  [7].  Estimation  of  ancestry  improves 
with panels of approximately 1,000,000 random markers 
compared  with  sparse  panels  of  AIMs,  leading  to 
increased statistical power and resolution for admixture 
mapping. Improved estimation of ancestry at the marker 
level results in decreased false-positive error rates and 
increased  power  for  association  mapping  due  to  the 
elimination of confounding by ancestry. Highly resolved 
estimation of local ancestry can also facilitate detection 
of  natural  selection  in  admixed  samples.  Improved 
estimation  of  ancestry  will  therefore  contribute  to 
mapping  of  disease  loci  as  well  as  contribute  to 
understanding demographic and adaptive history.
Population genetics of admixture
Conceptually, an admixed human population resembles 
an  advanced  intercross  between  outbred  populations 
with  the  admixed  individuals  having  variable  ancestry 
[8].  To  illustrate  the  salient  features  of  variation  in 
ancestry,  consider  two  isolated  populations  that  have 
experienced no interbreeding (Figure 1). In Generation 0, 
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which is simply a population of populations (Figure 1). At 
this  generation,  every  marker  in  the  genome  of  an 
individual  traces  its  ancestry  to  only  one  parental 
population.  Consequently,  ancestry  for  each  person  at 
each marker, known as local ancestry, is constant for each 
individual across all loci.
After  one  generation  of  random  mating  within  the 
meta-population,  an  individual  has  inherited  one 
chromosome from each parental population (Figure 1). 
Local ancestry is still uniform across all loci for a given 
individual. After a second generation of random mating 
and  beyond,  an  individual’s  genome  is  a  mosaic  of 
chromosomal  segments  with  ancestry  switching  from 
segment  to  segment  among  the  parental  populations 
(Figure  1).  An  ancestry  switch  refers  to  a  change  in 
ancestry in the interval between two markers and is the 
result  of  recombination  during  meiosis.  In  this  simple 
example, the proportion of ancestors from each parental 
population is equal for every admixed individual.
There  are  several  characteristics  of  admixed 
populations  that  are  relevant  to  disease  loci  mapping. 
First,  not  all  individuals  in  an  admixed  population 
necessarily have the same proportion of ancestors from 
each parental population. Second, all loci do not have to 
share  the  same  genealogical  history.  These  two 
characteristics  of  admixed  populations  are  sources  of 
variance  that  must  be  accounted  for  when  estimating 
local ancestry. Third, at any given locus, allele frequencies 
can vary between the parental populations. The expected 
allele frequency in the admixed population is the linear 
combination  of  the  allele  frequencies  in  the  parental 
populations  with  weights  determined  by  the  sample 
admixture  proportion.  Fourth,  the  admixed  population 
can  be  more  genetically  diverse  than  the  parental 
populations if a locus is not polymorphic with the same 
alleles in all parental populations. For example, suppose a 
locus  is  polymorphic  in  one  parental  population  and 
monomorphic  in  a  second  parental  population.  In 
addition, suppose a second locus is monomorphic in the 
first parental population and polymorphic in the second 
parental population. The admixed population is expected 
to be polymorphic at both loci. Fifth, similar to the way in 
which allele frequencies at a locus may vary, the patterns 
of covariance between allele frequencies at linked loci, 
known  as  linkage  disequilibrium,  can  also  differ.  As  a 
result,  the  distribution  of  haplotype  frequencies  in  the 
admixed population can be substantially different from 
the distributions of haplotype frequencies in the parental 
populations. These latter three characteristics of admixed 
populations  affect  how  many  markers  are  needed  for 
association mapping and the fine-mapping of functional 
variants.
Admixture mapping: from AIMs to random markers
Linkage disequilibrium caused by admixture that extends 
further  than  background  linkage  disequilibrium  in  the 
parental populations is the basis of admixture mapping 
[9,10].  Admixture  mapping  became  practical  in  2004 
with  the  development  of  statistical  methods  [11]  and 
panels of AIMs developed from reference databases [12] 
(for a historical overview of progress, see Winkler et al. 
[7]).  Essentially,  admixture  mapping  is  designed  to 
evaluate variation in ancestry. Tests of linkage are based 
on  assessing  the  relationship  between  phenotype  and 
local  ancestry  [13].  The  standard  case-control  design 
involves  a  comparison  of  local  ancestry  between  cases 
and  controls,  whereas  the  case-only  design  involves  a 
comparison of local ancestry to the average local ancestry 
[11,14,15].  The  average  local  ancestry  is  synonymous 
with  global  ancestry  and  the  individual  admixture 
proportion.
The next era of admixture mapping will benefit from an 
increased  density  of  markers.  Local  ancestry  can  be 
Figure 1. Schematic representation of population stratification 
and admixture. Population stratification can confound analysis 
of the meta-population in Generation 0 if allele frequencies differ 
between the two parental populations. Admixed individuals are 
generated by interbreeding among previously isolated populations. 
In subsequent generations, due to the cumulative effect of meioses, 
ancestry switches (that is, changes in ancestry in the interval 
between two markers) accumulate and chromosomes become 
mosaics of ancestry.
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Furthermore, given the distribution of local ancestry, we 
can  efficiently  estimate  global  ancestry  (Figure  2). 
However, despite ascertainment for ancestry informative-
ness, a sparse panel of AIMs does not extract as much 
information regarding ancestry as does a dense panel of 
random  markers  [16].  Dense  panels  provide  two 
advantages: increased sensitivity to smaller segments and 
higher  resolution  of  ancestry  switches.  The  average 
intermarker  distance  decreases  from  approximately 
1,500 kb for a typical panel of 2,000 AIMs to approxi-
mately 3 kb for a dense panel of 1,000,000 markers. As an 
example, in a sample of 1,976 African Americans [17], we 
detected a 1,027 kb segment of European ancestry in an 
African  background  with  the  intervals  for  the  left  and 
right switches localized to 35 kb and 1 kb, respectively. 
This  segment  is  undetectable  using  a  sparse  panel  of 
AIMs [18], as it lies entirely between flanking markers 
1,176 kb apart. Expanded to the genome-wide scale, how 
many random markers would it take to detect all ancestry 
switches?  By  examining  the  individual  with  the  most 
ancestry  switches  in  our  sample,  we  estimate  that  the 
number of random markers required is 177,000 (Figure 3), 
for which high-throughput genotyping will be more than 
sufficient. Some ‘failures’ of previous admixture mapping 
studies might have resulted from peaks of excess ancestry 
falling  between  AIMs.  Revisiting  these  studies  with 
denser panels might yield positive findings.
Figure 2. Local and global ancestry for three unrelated admixed African American individuals. Blue indicates two chromosomes of African 
ancestry, red indicates two chromosomes of European ancestry, and black indicates one chromosome of African ancestry and one chromosome 
of European ancestry. (a) An individual with a low proportion of African ancestry is depicted. (b) An individual with similar proportions of African 
and European ancestry is depicted. (c) An individual with a high proportion of African ancestry is depicted. The histograms on the right indicate the 
genome-wide frequencies of the three local ancestry values. Global ancestry equals the average of local ancestry divided by two (to account for 
diploidy). Among self-identified African Americans, the proportion of African ancestry can range from 0 to 1, representing the full range of variation. 
The information content of the local ancestry plots on the left is considerably higher than the global ancestry summaries on the right.
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characterization of the distribution of ancestry switches. 
By definition, ancestry switches are a subset of meiotic 
recombination events. The expected number of ancestry 
switches  can  be  calculated  using  a  fine-scale 
recombination  map  such  as  the  one  provided  by  the 
International  HapMap  Project  [19].  Deviation  between 
the observed and expected numbers of ancestry switches 
indicates  an  inconsistency  between  the  recombination 
map  and  the  sample.  A  trivial  explanation  for  such 
inconsistencies is error in the recombination map and/or 
the estimation of ancestry switches. Alternatively, fewer 
ancestry  switches  than  expected  given  the  local 
recombination  rate  might  reflect  negative  natural 
selection, whereas more ancestry switches than expected 
might reflect positive natural selection [20]. To illustrate, 
on chromosome 6p in our sample of African Americans, 
the  region  from  28  Mb  to  33  Mb  shows  an  excess  of 
ancestry  switches  (Figure  4).  This  region  includes  the 
major  histocompatibility  complex,  which  includes 
multiple immune response genes and is well known to be 
under positive natural selection. However, formal tests to 
evaluate  natural  selection  in  this  manner  await 
development. The distribution of ancestry switches also 
provides  information  with  respect  to  the  number  of 
generations since admixture began [21].
Two major challenges remain in admixture mapping. 
First,  inferring  ancestry  conditional  on  two  parental 
populations  is  generally  considered  to  be  solved,  but 
inferring ancestry for admixed populations with three or 
more  parental  populations  remains  challenging, 
particularly when the number of parental populations is 
unknown. As an example of three-way admixture, Puerto 
Rican  individuals  can  have  varying  proportions  of 
African,  European,  and  Native  American  ancestry 
[22,23]. Compared with a prevalence of 7.8% of asthma 
among European Americans, the prevalence of asthma 
among Puerto Ricans is 16.6% [24]. Second, admixture 
mapping  involves  testing  multiple  markers  across  the 
genome. To maintain control of the false-positive error 
rate  and  provide  maximum  power,  the  genome-wide 
significance  level  must  account  for  the  number  of 
markers  tested  while  accounting  for  correlation  of 
ancestry  between  markers.  Appropriate  genome-wide 
significance  levels  for  admixture  mapping  are  unclear 
[25-27]: for African Americans, estimates of the number 
of tests range from 400 [26] to 31,000 [27].
Refining association mapping in admixed 
populations
Association mapping is designed to evaluate differences 
in  genotype  frequencies.  The  major  challenge  for  this 
Figure 3. The effect of marker density on detecting ancestry 
switches. The number of ancestry switches detected as a function 
of marker density for the individual with the largest number of ancestry 
switches (n = 737) among 1,976 African Americans [17]. The continuous 
red line indicates the sparse panel of 1,943 ancestry-informative markers 
[18]. The dashed red line indicates saturation at 177,000 random 
markers, after which more markers provide no additional information 
regarding the number of ancestry switches. For admixed African 
Americans, high-throughput genotyping of approximately 1 million 
markers using commercially available microarrays is sufficient to 
extract all of the information on local ancestry.
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Page 4 of 8approach  in  admixed  populations  is  the  risk  of  false-
positive  genotype-phenotype  associations  due  to 
variation in ancestry [28]. There are several techniques to 
control  for  this  form  of  confounding  for  samples  of 
ancestrally homogeneous individuals, including genomic 
control,  structured  association  testing,  principal 
components,  variance  components,  and  propensity 
scores  [16,29,30].  These  techniques  control  for 
confounding  at  the  level  of  the  individual  but  none 
controls for confounding at the level of specific markers 
such as SNPs [31].
Global  ancestry  as  a  covariate  will  control  for 
confounding  due  to  variation  in  individual  ancestry  if 
there  are  no  marker-specific  ancestry  effects  and 
genotypic effects are additive [32]. If there are marker-
specific ancestry effects, or if genotypic effects are not 
additive,  it  is  important  to  measure  local  ancestry  to 
control  for  confounding  due  to  admixture  (Table  1). 
Accounting for local ancestry can also improve power of 
association testing if there are both local ancestry and 
genotypic  effects  at  the  same  marker  (Table  1). 
Controlling for local ancestry will not necessarily control 
for  confounding  due  to  global  ancestry  because  local 
ancestry and global ancestry are weakly correlated [33]. 
Therefore,  control  of  confounding  due  to  admixture 
requires conditioning on both local and global ancestry.
One  way  to  control  for  confounding  due  to  local 
ancestry in association mapping is to simply include local 
ancestry  as  an  additive  covariate.  This  parametric 
approach  assumes  that  the  effect  of  local  ancestry  is 
additive,  analogous  to  the  additive  genetic  model  for 
genotypes. Alternatively, a non-parametric approach to 
control for confounding due to local ancestry is stratified 
regression. Specifically, when testing for association at a 
locus,  one  actually  performs  separate  regressions  with 
the  subgroups  defined  by  local  ancestry.  The  separate 
regressions  can  then  be  pooled  to  generate  inverse 
variance-weighted  regression  coefficients  and  standard 
errors.  One  can  also  perform  subgroup  analyses.  For 
example,  differences  in  effect  sizes  at  a  locus  can  be 
tested by Welch’s t test, and differences in reference allele 
frequencies  can  be  tested  using  a  test  of  proportions 
between subgroups. These tests help to address the issue 
of  heterogeneity  of  genetic  associations  across  popula-
tions. Furthermore, we can jointly test for genotype and 
ancestry effects at each marker [34].
Imputation is commonly used in association studies to 
‘fill  in’  genotypes  for  untyped  markers  by  leveraging 
external data on patterns of linkage disequilibrium [35]. 
For example, the HapMap [19] or 1000 Genomes CEU 
[36]  data  provide  reference  data  regarding  linkage 
disequilibrium  patterns  relevant  for  association  studies 
comprising  samples  of  similar  European  ancestry.  For 
admixed  samples,  each  parental  population  may  be 
represented by a separate reference data set. However, it 
is not yet clear how best to utilize multiple reference data 
sets  to  maximize  imputation  accuracy  [37].  Ancestry-
aware  imputation  can  be  more  accurate  than  not 
accounting for local ancestry [38].
In  direct  contrast  to  the  situation  with  admixture 
mapping,  approximately  1  million  markers  are  barely 
sufficient to saturate background linkage disequilibrium 
in  association  mapping  in  populations  of  European  or 
East Asian ancestry and insufficient for populations of 
African  ancestry,  as  they  are  more  genetically  diverse 
[19].  In  addition  to  weaker  background  linkage 
disequilibrium  in  populations  of  African  ancestry 
compared  with  those  of  European  ancestry,  there  are 
more low-frequency and rare variants in populations of 
African  ancestry  [36].  Whole-genome  sequencing  can 
contribute  substantially  to  association  mapping  by 
eliminating the use of tagging variants that achieve poor 
coverage  in  genomic  regions  of  weak  linkage 
disequilibrium  and  by  discovering  all  genetic  variants 
regardless of frequency. Compared with high-throughput 
genotyping, sequencing will also expedite finding causal 
variants (that is, genetic variants directly associated with 
the phenotype of interest).
Success stories
Several  success  stories  of  disease  loci  mapping  in 
admixed  populations  have  been  reported  [7,39], 
Table 1. Controlling for confounding due to admixture in 
association testing
  Generative modela  Regression modeld
        Genotype 
      Genotype and  stratified by 
βgenotype
b  βlocal ancestry
c  Genotype  global ancestry  local ancestry
0  0  0.048  0.044  0.053
0  1  0.570  0.538  0.052
1  0  0.892  0.892  0.893
1  1  0.599  0.626  0.899
The first two rows demonstrate inflation of the false-positive error rate resulting 
from confounding due to admixture. The second two rows demonstrate the 
loss of power resulting from confounding due to admixture. In both cases, 
confounding is controlled by local ancestry but not by global ancestry. aTwo 
isolated parental populations were generated with FST = 0.115 (FST is the ratio of 
the observed variance in allele frequencies among populations to the variance 
expected if the populations were randomly mating), mimicking the amount 
of population differentiation between the African and European ancestors of 
African Americans. A sample of admixed individuals was generated with 80% 
of the genome inherited from the first parental population, mimicking the 
amount of African ancestry in African Americans. A dataset consisted of 1,000 
unrelated individuals and 1,000 unlinked markers. The generative model for 
the phenotype was a linear model with the listed fixed effects for the queried 
marker, no effects for all other markers, and noise equal to a random deviate 
from the standard normal distribution. bFor each marker and individual, the 
genotype was coded as 0, 1, or 2 copies of the derived allele. cFor each marker 
and individual, local ancestry was coded as 0, 1, or 2 copies inherited from the 
first parental population. dThe rejection rates (false-positive error rates if βgenotype 
= 0, or power if βgenotype = 1) for testing genotype association at one marker are 
shown. The significance level was 0.05.
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cancer, and kidney disease. The two diseases for which 
fine-mapping  of  the  original  admixture  signal  has 
proceeded the furthest are prostate cancer and end-stage 
kidney disease.
An admixture signal on chromosome 8q24 was found 
for prostate cancer in African Americans [40]. The same 
locus was detected by linkage analysis in Icelanders [41]. 
At least three blocks of linkage disequilibrium containing 
several  independently  associated  variants  have  been 
identified  within  this  locus  [41-44].  Molecular  studies 
identified  enhancer  elements  for  the  oncogenic 
transcription  factor  MYC  that  regulate  tissue-specific 
expression  patterns,  which  potentially  explain  why  the 
locus  affects  risk  for  breast  and  colorectal  cancer  in 
addition  to  prostate  cancer  [45-51].  One  of  these 
enhancers  interacts  with  the  MYC  promoter  through 
binding  of  the  transcription  factor  complex  β-catenin/
TCF7L2 [46,50]. TCF7L2 is the most strongly associated 
gene for type 2 diabetes [52], providing in part a genetic 
basis for the epidemiological association between these 
two  diseases.  Thus,  although  the  original  admixture 
signal was detected for prostate cancer, ongoing follow-
up studies indicate that the locus also influences breast 
cancer, colorectal cancer, and type 2 diabetes.
An admixture signal on chromosome 22q13 was found 
for focal segmental glomerulosclerosis, a cause of end-
stage  kidney  disease,  in  African  Americans  [53,54]. 
Originally, the candidate gene underlying this signal was 
thought to be MYH9, which encodes non-muscle myosin 
heavy chain 9 and is highly expressed in kidney podocytes 
[53,54]. Sequence data from the 1000 Genomes Project 
[36]  included  newly  discovered  variants  in  a  part  of 
chromosome  22q13  that  had  poor  coverage  in  the 
International  HapMap  Project  [55].  Using  the  more 
comprehensive  sequence  data,  it  now  appears  that  the 
major  effect  gene  is  that  encoding  apolipoprotein  L1, 
which is in linkage disequilibrium with MYH9 [56]. The 
protein  product  apolipoprotein  L1  has  trypanolytic 
activity;  the  gene  locus  appears  to  be  under  balancing 
selection for protection against sleeping sickness at the 
cost of increased risk for end-stage kidney disease [56]. 
Starting  from  the  original  admixture  signal,  sequence 
data have permitted fine-mapping, with the majority of 
the signal resolved to two alleles located in the last exon 
of the gene encoding apolipoprotein L1 [56].
Admixed populations: how many markers should 
one use?
In the USA, the two most commonly studied admixed 
populations  are  African  Americans  and  Latino 
Americans. Both of these populations are characterized 
by less than 25 generations since admixture began as a 
result of maritime European expansion. For both of these 
admixed  populations,  the  parental  populations 
genetically differ at the intercontinental level. Population 
differentiation is often measured by FST, which is defined 
as the ratio of the observed variance in allele frequencies 
among  populations  to  the  variance  expected  if  the 
populations  were  randomly  mating.  FST  at  the 
intercontinental level is generally greater than 0.10 [55]. 
Other examples of admixed populations with this level of 
population differentiation include Ashkenazi Jews (who 
have  Eastern  European  and  Middle  Eastern  ancestry), 
South  African  Coloureds  (who  have  Bantu-speaking 
African, European, Indian, Khoisan, and Southeast Asian 
ancestry), Australian Aboriginals (who have Aboriginal 
and European ancestry), and Pacific Islanders (who have 
European and Polynesian ancestry) [7].
We  estimate  that  <200,000  random  markers  (that  is, 
markers  not  ascertained  for  ancestry  informativeness) 
are  sufficient  to  saturate  the  signal  of  linkage 
disequilibrium  due  to  admixture  in  the  context  of 
admixture  mapping  for  African  Americans.  A  higher 
density  of  markers  may  enable  detection  of  older 
admixture, because the number of ancestry switches (and 
the  number  of  markers  required  to  detect  all  of  those 
ancestry switches) increases as the number of generations 
since  admixture  began  increases.  As  a  first-pass 
approximation,  a  sample  is  well  powered  to  detect 
population structure if 1/FST exceeds the geometric mean 
of the number of unrelated individuals and the number of 
independent  markers  [57].  With  a  sufficiently  large 
sample and dense markers, it might be possible to detect 
admixture among parental populations that differ at the 
intracontinental  level,  or  FST  of  the  order  of  0.01  [57], 
which is relevant for analysis of Northern Europe versus 
Southern Europe [57] and East Asian populations [58]. It 
also may be possible to detect admixture that occurred 
more distantly in the past (for example, approximately 
100  generations  ago),  for  example,  in  the  Uyghurs  in 
western  China  (who  have  European  and  East  Asian 
ancestry)  [59].  At  a  more  ancient  level,  Tishkoff  et  al. 
reported evidence of admixture between Bantu-speaking 
Africans  and  Khoisans  [60].  At  an  even  more  ancient 
level, the proportion of Neandertal ancestry of Eurasians 
has  been  estimated  to  be  between  1%  and  4%  [61]. 
Characterization of populations with complex patterns of 
admixture  can  contribute  substantially  to  our 
understanding  of  population  history  and  can  also 
contribute to understanding complex disease.
Bright prospects for the future
The  convergence  of  high-throughput  genotyping  or 
sequencing  and  new  methods  to  infer  local  ancestry 
allows  for  joint  admixture  and  association  analysis. 
Furthermore, sensitivity to detect admixture afforded by 
the combination of larger samples, denser markers, and 
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admixture events and admixture between more closely 
related populations. Improved estimation of ancestry will 
benefit association mapping in admixed populations by 
eliminating the effects of confounding due to variation in 
ancestry.  High-throughput  genotyping  and  sequencing 
will enable refined estimation of ancestry, making disease 
loci identification in admixed populations more powerful.
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